Journal article

Hypotensive effects of ghrelin receptor agonists mediated through a novel receptor

Brid Callaghan, Samin Kosari, Ruslan V Pustovit, Daniela M Sartor, Dorota Ferens, Kung Ban, Jonathan Baell, Trung V Nguyen, Leni R Rivera, James A Brock, John B Furness

BRITISH JOURNAL OF PHARMACOLOGY | WILEY | Published : 2014

Abstract

BACKGROUND AND PURPOSE: Some agonists of ghrelin receptors cause rapid decreases in BP. The mechanisms by which they cause hypotension and the pharmacology of the receptors are unknown. EXPERIMENTAL APPROACH: The effects of ligands of ghrelin receptors were investigated in rats in vivo, on isolated blood vessels and on cells transfected with the only molecularly defined ghrelin receptor, growth hormone secretagogue receptor 1a (GHSR1a). KEY RESULTS: Three agonists of GHSR1a receptors, ulimorelin, capromorelin and CP464709, caused a rapid decrease in BP in the anaesthetized rat. The effect was not reduced by either of two GHSR1a antagonists, JMV2959 or YIL781, at doses that blocked effects on..

View full abstract